PMC:7279430 / 51599-51820 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T175","span":{"begin":199,"end":204},"obj":"Body_part"}],"attributes":[{"id":"A175","pred":"fma_id","subj":"T175","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"Zingiber officinale Roscoe α-zingiberene (26.4%), camphene (12.6%), β-sesquiphellandrene (9.2%), ar−curcumene (6.5%), β-phellandrene (6.2%), and β-bisabolene (5.1%) c Plaque reduction assay (RC-37 cells), HSV-1 2 [56]"}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"2389","span":{"begin":0,"end":26},"obj":"Species"},{"id":"2390","span":{"begin":207,"end":212},"obj":"Species"}],"attributes":[{"id":"A2389","pred":"tao:has_database_id","subj":"2389","obj":"Tax:94328"},{"id":"A2390","pred":"tao:has_database_id","subj":"2390","obj":"Tax:10298"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Zingiber officinale Roscoe α-zingiberene (26.4%), camphene (12.6%), β-sesquiphellandrene (9.2%), ar−curcumene (6.5%), β-phellandrene (6.2%), and β-bisabolene (5.1%) c Plaque reduction assay (RC-37 cells), HSV-1 2 [56]"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T589","span":{"begin":199,"end":204},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"Zingiber officinale Roscoe α-zingiberene (26.4%), camphene (12.6%), β-sesquiphellandrene (9.2%), ar−curcumene (6.5%), β-phellandrene (6.2%), and β-bisabolene (5.1%) c Plaque reduction assay (RC-37 cells), HSV-1 2 [56]"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T25287","span":{"begin":30,"end":41},"obj":"Chemical"},{"id":"T44025","span":{"begin":51,"end":59},"obj":"Chemical"},{"id":"T75551","span":{"begin":101,"end":110},"obj":"Chemical"},{"id":"T98605","span":{"begin":121,"end":133},"obj":"Chemical"},{"id":"T79213","span":{"begin":148,"end":158},"obj":"Chemical"}],"attributes":[{"id":"A91394","pred":"chebi_id","subj":"T25287","obj":"http://purl.obolibrary.org/obo/CHEBI_10115"},{"id":"A69629","pred":"chebi_id","subj":"T44025","obj":"http://purl.obolibrary.org/obo/CHEBI_3830"},{"id":"A95959","pred":"chebi_id","subj":"T75551","obj":"http://purl.obolibrary.org/obo/CHEBI_62757"},{"id":"A72502","pred":"chebi_id","subj":"T98605","obj":"http://purl.obolibrary.org/obo/CHEBI_50034"},{"id":"A37113","pred":"chebi_id","subj":"T79213","obj":"http://purl.obolibrary.org/obo/CHEBI_49235"},{"id":"A91073","pred":"chebi_id","subj":"T79213","obj":"http://purl.obolibrary.org/obo/CHEBI_49237"}],"text":"Zingiber officinale Roscoe α-zingiberene (26.4%), camphene (12.6%), β-sesquiphellandrene (9.2%), ar−curcumene (6.5%), β-phellandrene (6.2%), and β-bisabolene (5.1%) c Plaque reduction assay (RC-37 cells), HSV-1 2 [56]"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T401","span":{"begin":0,"end":221},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Zingiber officinale Roscoe α-zingiberene (26.4%), camphene (12.6%), β-sesquiphellandrene (9.2%), ar−curcumene (6.5%), β-phellandrene (6.2%), and β-bisabolene (5.1%) c Plaque reduction assay (RC-37 cells), HSV-1 2 [56]"}